Kimberly Gentile
SVP, Clinical Operations · Biohaven Ltd.
Individual
- 2026
- Sep 17, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kimberly Gentile files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John W. Childs - $25.86M in BHVN purchases and sales in the last 12 months
- Vlad Coric - $5.00M in BHVN purchases and sales in the last 12 months
- Gregory Bailey - $3.00M in BHVN purchases and sales in the last 12 months
- George C. Clark - $145K in BHVN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kimberly Gentile?
Kimberly Gentile is a corporate insider, tracked as SVP, Clinical Operations of Biohaven Ltd. (BHVN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kimberly Gentile submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.